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Accepted 17 March 2014; Published online 5 May 2014AbstractObjective: The aim of the study was to investigate how doctors considered and experienced the concept of equipoise while recruiting
patients to randomized controlled trials (RCTs).
Study Design and Setting: In-depth interviews with 32 doctors in six publicly funded pragmatic RCTs explored their perceptions of equi-
poise as they undertook RCT recruitment. The RCTs varied in size, duration, type of complex intervention, and clinical specialties. Interview
data were analyzed using qualitative content and thematic analytical methods derived from grounded theory and synthesized across six RCTs.
Results: All six RCTs suffered from poor recruitment. Doctors wanted to gather robust evidence but experienced considerable discom-
fort and emotion in relation to their clinical instincts and concerns about patient eligibility and safety. Although they relied on a sense of
community equipoise to justify participation, most acknowledged having ‘‘hunches’’ about particular treatments and patients, some of
which undermined recruitment. Surgeons experienced these issues most intensely. Training and support promoted greater confidence in
equipoise and improved engagement and recruitment.
Conclusion: Recruitment to RCTs is a fragile process and difficult for doctors intellectually and emotionally. Training and support can
enable most doctors to become comfortable with key RCT concepts including equipoise, uncertainty, patient eligibility, and randomization,
promoting a more resilient recruitment process in partnership with patients.  2014 The Authors. Published by Elsevier Inc. All rights
reserved.
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Recruitment to randomized controlled trials (RCTs) is
difficult. Approximately 50% of initiated RCTs reach their
original recruitment target [1], and poor recruitment under-
mines the power of RCTs to answer key questions and their
external validity and leads to considerable waste of research
resources. Most research on RCT recruitment has focused on* This is an open access article under the CC BY license (http://
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http://dx.doi.org/10.1016/j.jclinepi.2014.03.010ways of increasing patient participation, for example, by
providing additional or favorable information [2] or
comparing lengths of information sheets [3]. However, sys-
tematic reviews have identified only a small number of suc-
cessful interventions directed at patients [4] and pointed to
the lack of prospective research in ongoing RCTs and studies
involving recruiters [5]. The research that has been done with
recruiters includes a survey of pediatricians that suggested
that their views could influence levels of participation [6]
and two studies that have indicated that difficulties with
equipoise can act as a barrier to recruitment to RCTs [7,8].
There has been considerable debate about the concept of
‘‘equipoise’’ in relation to RCTs since the study design was
first formally recognized in the 1940s. At the heart of the
debate is the need to justify the recruitment of patients to
studies incorporating an experiment rather than ensuring
they receive the best medical care under a physician’sAll rights reserved.
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 Poor recruitment threatens the validity of random-
ized controlled trials (RCTs) and their power to
answer key health-care questions and wastes
research resources, and this study has illuminated,
from the recruiter’s perspective, why it is such a
fragile process.
 Doctors in these RCTs were keen to participate in
RCTs to gather high-quality evidence, but they
struggled intellectually and emotionally with the
conflicts between the needs of the RCTs and their
clinical instincts, treatment preferences, and con-
cerns about patient eligibility and safety.
 Equipoise was relatively easy for doctors to define
in general terms and particularly as uncertainty
among a community of experts, but it became a
much more elusive concept when they attempted
to recruit patients with particular clinical character-
istics to the RCT.
 Doctors need training and support to enable them
to become more familiar and comfortable with
key RCT concepts including equipoise so that they
can engage more easily with patients and partici-
pate in a more resilient recruitment process.
guidance. Bradford Hill [9] established the principle that a
doctor should only include a patient in an RCT if they could
claim ‘‘no knowledge that one treatment will be better or
worse, safer or more dangerous than another.’’ The term
equipoise was later defined by Fried [10], ‘‘where the bal-
ance of opinion is truly in equipoise, there is no sense to the
accusation that the prescribing of the one or the other of the
equally eligible treatments can constitute a withholding of
anything or can constitute doing less than one’s best.’’
Over time and with the growth in numbers of RCTs
carried out, there has been a shift toward an acknowledg-
ment that the conduct of RCTs could be justified by a lack
of satisfactory evidence and consensus among experts
about the comparative merits of treatments [11]. In the
late 1990s, the concept of ‘‘uncertainty’’ was then
advocateddthat an RCT could be undertaken when doctors
were uncertain [12] or ‘‘substantially’’ uncertain [13], or
there was consensus about uncertainty among a community
of doctors [14]. In more recent years, the debate has
become polarized between those strongly advocating the
need for the concept of equipoise to provide legal and
ethical justification for RCTs [15,16] and others rejecting
it as unnecessary and impossible to operationalize [17,18].
A research program was undertaken to understand the
recruitment process in pragmatic RCTs experiencing, or
expecting to experience, poor recruitment and, wherepossible, to provide feedback to improve recruitment
[15]. Interviews undertaken with doctors from different
specialties focused on how the concepts of equipoise and
uncertainty were used in everyday practice and revealed
the practical and emotional consequences as doctors strug-
gled to reconcile the conflicts they experienced in their clin-
ical and research roles. Training and support needs were
identified for doctors to help them negotiate the fragile pro-
cess of RCT recruitment with patients.2. Study design and setting
RCTs that were experiencing, or expecting to experience,
poor recruitment were identified through contact with fund-
ing bodies and informal communication with trialists. The
chief investigators (CIs) of seven RCTs were approached
and asked to participate in an integrated qualitative study
of recruitment [19]. The CIs were asked to be interviewed
and to identify key RCT personnel and staff undertaking
recruitment in the RCTs who could be approached to be in-
terviewed about recruitment. All seven CIs agreed to partic-
ipate; in one RCT, recruitment started well, and so the
qualitative research was not undertaken. The six RCTs
included were pilot/feasibility studies, pragmatic in design,
funded by national bodies, and encompassed a range of clin-
ical contexts, different types of intervention, and types of
recruitment staff (Table 1). Ethical approval was obtained
within the governance arrangements of each RCT. Inter-
views were undertaken with the CI and doctors actively
involved in recruitment who agreed to participate in the
qualitative research. Consent was obtained for interviews
to be audio recorded. Views about equipoise were sought
through in-depth interviews using a checklist of topics to
ensure that similar issues were covered with participants
while enabling other issues of importance to emerge. Inter-
views were conducted between 2001 and 2009 by Zelda
Tomlin, S.P., I.d.S., M.T., or Gavin Daker-White, mostly
face-to-face or by telephone when participants were difficult
to reach, with some in groups when recruiters met for study
purposes. In four RCTs, follow-up interviews were carried
out with 15 recruiters (Table 1).
Interviews were transcribed in full, and data were
analyzed using qualitative content and thematic analysis
methods, based on the techniques of constant comparison
and grounded theory [26,27]. Data relating to uncertainty
and equipoise were extracted from the original interview
transcripts and systematically coded, analyzed, and synthe-
sized by J.L.D. in 2011e2013 to identify similarities and
differences across the RCTs in how the concepts were
considered and experienced and to investigate implications
for recruitment and training needs.3. Results
The six pragmatic RCTs varied in terms of size and dura-
tion and encompassed a range of clinical specialties and
Table 1. RCT names, designs, contextual characteristics, and numbers of study participants
RCT
code
RCT
acronym
(see
footnotes
for details) RCT type
Clinical
centers,
n Interventions
Specialties
involved
Primary
recruiters
Dates of
interviews
Doctor
interviews,
n
Follow-up
doctor
interviews, n
Total
number of
interviews,
n
T1 EaStER [20] Feasibility 5 Laser surgery or
radiotherapy
Surgery and
oncology
Doctors and
nurses
2005 3 Surgeons 3 (1 group) 6
T2 FACS [21] Main 28 Follow-up
strategies
from low to high
intensity
Primary care
and oncology
Doctors and
nurses
2005 1 GP,
2 surgeons
3 (1 group) 6
T3 PITCH [22] Main 1 Area
(multiple
locations)
Ibuprofen or
paracetamol or
both
Primary care
and pediatrics
Nurses 2005 2 GPs 0 2
T4 SWAN [23] Main 2 Areas
(multiple
locations)
Support for work
or usual care
Psychiatry,
community
services
Nurses and
others
2006 3 Community
mental health
2 (1 group) 5
T5 ProtecT [24] Feasibility
and main
9 Surgery or
radiotherapy
or monitoring
Surgery and
oncology
Doctors and
nurses
2001/
2002,
2006
12 Surgeons,
1 oncologist
7 Surgeons 20
T6 SPARE [25] Feasibility 22 Chemotherapy
with surgery
or with
radiotherapy
Oncology and
surgery
Doctors 2009 4 Oncologists,
4 surgeons
0 8
Total 32 15 47
Abbreviations: RCT, randomized controlled trial; GP, general practitioner.
Box 1 Community equipoise
T6-D4: With T6, like any clinical trial, it’s the idea
of clinical equipoise, that you have to be able to put
your hand on your heart and say that you’d be happy
for your patient to get any of the treatments in the
trial. You don’t think that one of them is worse than
the other, and what we’re trying to find out is if one is
better than the other because we don’t currently have
the evidence to say one way or the other.
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specialist hospital doctors, general practitioners, nurses,
and other clinical staff conducting recruitment were inter-
viewed (72 in total). The focus of this analysis was on doc-
tors in clinical practice who were actively involved in
recruitment and for whom equipoise was most relevantd32
in total, 15 of whom were interviewed on more than one
occasion (Table 1). There were 21 surgeons and 11 special-
ists from primary care, oncology, or psychiatry. All doctors
readily discussed their involvement in the RCTs, the chal-
lenges of recruitment, and issues related to equipoise or un-
certainty. In the presentation of findings below, quotations
have been provided to support the analysis, some of which
are included in the Appendix at www.jclinepi.com.
Interviewee details have been anonymized to protect confi-
dentiality and labels used to indicate the doctor and RCT
(eg, T8-S1 (RCT8 surgeon 1) or T8-D2 (RCT8 other
specialist 2)) and whether the interview was in a group
(-G) or follow-up (-F).
3.1. Individual or community equipoise
Some doctors defined themselves as being in ‘‘individual’’
equipoisedconvinced that RCT treatments were suitable for
eligible patients, but most relied on a sense of ‘‘community’’
equipoise arising from a lack of evidence and consensus
among colleagues about the best treatment (Box 1).
3.2. Difficulties and discomfort in relation to equipoise
As the doctors discussed equipoise and their roles and
responsibilities in relation to RCT recruitment and clinicalpractice, they expressed considerable discomfort, revealing
views that were emotional and intellectual. Three inter-
linked sources of discomfort emerged: the perceived eligi-
bility of individual patients or groups for the RCT;
the different roles and responsibilities required for RCT
participation compared with routine clinical practice; and
the tensions between the wish to gain robust evidence
and doctors’ clinical judgments and personal intervention
preferences.
3.2.1. Equipoise and patient eligibility
Doctors were most comfortable when they considered
equipoise in general terms, for example, in relation to
health-care resources or populations (Box 2). Most also
found it relatively easy to approach patients and recruit
them to the RCT when they fitted a perceived ‘‘core’’ set
of eligibility criteria. Discomfort arose when doctors
considered individual patients, or groups of patients, with
Box 2 Equipoise and eligibility
T2-D1: I think the uncertainty is about the cost
effectiveness of follow up . There’s a trade off for
the individual to [take part in this RCT] ... For the
NHS though the trade-off is the cost of doing this
intensive imaging compared to the number of life
years gained.
T5-S10: I’ve not found it [equipoise] personally
difficult in concept, because I’ve been absolutely
convinced that we don’t know which is the best treat-
ment and although surgery may be a better procedure
for cancer cure it has such a high impact that a small
number of people might benefit and it’s quite a few
who are paying a heavy price to get that. So I’ve
not really had any difficulty in that. I think where
it’s got difficult, I would say is, in a group of patients
that intuitively I feel might do better with active treat-
ment . I know intellectually there’s no evidence
about treatment in particular sub-groups, but ...
there’s little sub groups where I’ve found it more
difficult than others, and that’s inevitable, I think.
Box 3 Routine practice compared with RCT
recruitment
T2-D1: [In clinical practice] I have to make a de-
cision and in the other I don’t and that’s why I prefer
trials . I can hide behind a trial, I don’t have to
make a decision. I’m doing the best for the patient
because I genuinely don’t know; we’re doing the best
for society because hopefully we’ll get that answer
out.
T5-S4-F: I think that the main difference is that [in
clinical practice] I have to steer them to a choice, that
there is a specific choice. I can’t steer them to equi-
poise because equipoise is the worst possible
outcome for them isn’t it? . You give them argu-
ments that build up their feeling about that particular
option.
Box 4 Evidence and clinical ‘‘gut’’ instincts
T6-D4: We don’t have the evidence and people’s
choice of one treatment or another is based predom-
inantly on a sort of prejudice. So if you see an oncol-
ogist first, they may be more likely to suggest
radiotherapy; if you see a surgeon they may be more
likely to suggest surgery.
T2-D1: Yes as a clinician, I’m in equipoise. Yes I
know my gut feelings are not to do with my clinical
judgment or activity. I don’t base my clinical activity
on that feeling. I’m very, very distrustful of my gut
feeling.
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on the ‘‘edges’’ of their perceived core of eligibility. There
were considerable differences between doctors in their per-
sonal boundary between the core and edges of eligibility,
and their boundaries did not always accord with the formal
criteria in the RCT protocol. Some doctors had clear views
about the most beneficial treatment for edge patients and
did not recruit them, whereas others proceeded to recruit,
with varying degrees of discomfort depending on their
commitment to the RCT (Box 2).
3.2.2. Routine clinical practice, RCT recruitment, and
evidence
When doctors compared RCT recruitment with clinical
practice, they identified conflicting aspects of their role in
decision making with varying degrees of comfort. Recruit-
ing patients to RCTs required them to express uncertainty,
and so lack of evidence and equipoise were useful concepts.
In routine clinical practice, they had to reach a decision
with the individual patient quickly, based on their judg-
ments, often in situations without clear evidence. Doctors
varied in terms of which context they found most comfort-
able (Box 3).
Most doctors were disappointed that evidence was lack-
ing in so many areas, leaving them to rely on instinctive
rather than evidence-based clinical judgments. Again, there
was evidence of emotion and discomfort, with clinical judg-
ments sometimes referred to somewhat pejoratively as ‘‘gut
instincts,’’ ‘‘prejudices,’’ or ‘‘hunches’’dwith doctors
committed to the RCTs trying hard to rely on judgments on-
ly when they were lacking robust evidence (Box 4).3.2.3. Equipoise, ‘‘hunches,’’ and intervention preferences
Although these doctors reported relying on community
or individual equipoise when recruiting patients, they did
not always express personal uncertainty. Some hoped that
one treatment (usually their own) might be better than
another, and others participated in the RCT because they
had clear confidence in their preferred treatment (Box 5).
Under the umbrella of community equipoise, some special-
ists, particularly surgeons, had absolute clarity about the su-
periority of their own specialty approaches (Box 5).
The degree to which these views impacted on recruit-
ment is considered below.
3.3. Equipoise and the fragility of RCT recruitment
All these RCTs were experiencing recruitment diffi-
culties. Although doctors often reported relying on a sense
of community equipoise arising from their knowledge of
the lack of robust evidence and the existence of a fully
funded and approved RCT to justify their participation,
many expressed sometimes very strong personal beliefs
Box 5 Personal/clinical convictions
T6-D1: I wouldn’t be entering patients if I knew
what the trial was going to show because I wouldn’t
have the equipoise required for randomisation. But
I’d quite like it to show that organ preservation is at
least as good as surgery.
T6-S5: I think the radiotherapists should believe in
radiotherapy and I think surgeons believe in surgery.
And I think that’s probably pretty normal actually. To
tell you the truth, I believe in surgery because I’m a
surgeon. And I think what we’ll find out from the
study is whether the radiotherapy treats as well as
we do.
T5-S6-F: I don’t know, and I believe that that’s
why I’ve got equipoise. I don’t know. I would say that
to them [patients] . I don’t know, you don’t know,
nobody knows. That’s why it has to be randomized
. Good quality surgery’s the best option but I accept
that that’s not been shown, you know. I accept that it
needs to be shown and if you, I think what you’re
asking me is how do I persuade a patient if I don’t
believe it myself?.Well, the answer is it’s not been
shown so it’s only a hunch and that’s what bias is so I
put my biases aside. But if they pin me down and they
say, ‘‘do you think the earlier you get it the more
likely you are to cure it?’’ Well I’ve got to say,
‘‘yes’’ because I think that, you know.
Box 7 The absence of equipoise
T1-S3-F-G: The real thing that swings it for me, if
I was faced with this decision I’d have surgery with
somebody who would do it properly, for the sole
reason that if I have another tumour and I have radio-
therapy, it’s done and dusted. It gives me multiple
treatment options, I can still have more surgery, I
can have more extensive surgery and I can still have
radiotherapy afterwards and that would be for me
personally the key argument.
Interviewer: But then you don’t have equipoise
personally.
T1-S3-F-G: Umm I don’t.
T1-S1-F-G: And you are truly wonderful, [name],
but you are still a surgeon, you are still a surgeon
and if we had a radiotherapist sitting there they’d
say actually in my hands the side effects are very tiny,
because they’re talking about a small field . they
protect things. It is really very minimal.
T5-S8: There’s a proportion of patients who will
say to me, ‘‘What do you think doctor?’’ And in that
situation, I think my gut feeling is important. I always
tell them . I wouldn’t have become a surgeon if I
thought another form of therapy was the best form
of therapy, would I? So my preference does matter
to some patients but, you know, it’s important for
them in my opinion to also go and talk to the radio-
therapist who, presumably, will be more passionate
about their treatment.
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relation to specific patient groups. At times, this contradic-
tion caused considerable discomfort, although only a small
number thought that their views affected recruitment
(Box 6)dthe majority cited organizational difficulties,
fewer than expected eligible patients, and strong patient
treatment preferences [28].
Most seemed able to state that they were ‘‘in equipoise’’
and believe that they could put aside their personal prefer-
ences while recruiting. But RCTs T1, T6, and the feasibilityBox 6 The impact on recruitment
T6-S5: I think the younger people with a cancer
might be better off having surgery because of the
long-term risks of getting a recurrence after radio-
therapy and what that means for them in terms of sur-
vival. So I probably do have an underlying bias
towards surgery. Then again that’s what I do so I
think as long as you recognise that then if they are
deemed eligible then they should all be given all
the options. Whether my biases come out, I don’t
know. I try not to.phase of T5 had the clearest evidence of strong specialty
convictions and the most severe recruitment difficulties.
These were RCTs with a surgery arm. Doctors, particularly
surgeons, described the conflicts between their sense of
equipoise, specialty pride, and personal choice, with some
revealing that they really were not in equipoise at all
(although they continued to be involved in the RCT; Box 7).3.4. The potential for equipoise to change over time: the
role of training and support
The doctors with more experience of taking part in
RCTs reported that community equipoise could change
over timedfor some RCTs to the detriment of recruitment,
but others mentioned that a change in the protocol or
increased confidence in the RCT could lead to equipoise
become more comfortable (Box 8).
In T5, a training and feedback program was developed
for recruiters (doctors and nurses) based on the findings
of qualitative research integrated into the RCT [29]. Ele-
ments of the recruitment intervention were applied to the
other five RCTs but in a limited way because of financial
Box 8 Change over time
T4-D1: Well, from the beginning to eighteen
months into the trial, the field changed within which
the study was taking place and I think we’d underes-
timated that. Staff have a feeling that to cut out, as
they see it, the option of referring to [the interven-
tion] might deprive the patient of something valuable.
Now, we don’t know if it’s a deprivation because
we’ve no idea if this works yet . but in their eyes,
it is, you knowdI can see why they’d think that.
T6-S5: When I first went into it and the surgeons
were saying ‘‘oh, well, we don’t think so.’’ and
you know, I’m thinking, ‘‘should we be doing this?’’
So I think you do have to get yourself to a point
where you feel comfortable with all that’s on offer.
I mean, quite often when you start a study, you don’t
always, necessarily . And the more you find out,
usually, the more you realize, ‘‘well, actually, yeah,
this study is pretty important, we don’t really know.’’
Box 9 Training and feedback
T5-S7: I found the [training] meeting [about T5]
fascinating. Because you don’t realise all the preju-
dices that you do have until you talk to other people
about it and you talk about a trial like this and you
realise that you are making lots of assumptions, and
the main assumption is that as a surgeon you’re doing
good. Do you know what I mean? If you get rid of
something you’re doing some good. But you’ve got
to critically evaluate that. It’s hard. It’s hard to be
honest and say, ‘‘I’m doing all this work, slaving
away and actually, have I achieved anything?’’
T5-S9: Becoming slightly more, I hate that word,
but in ‘‘equipoise’’. I try to do that now. I think, I
thought I was trying to do that before, but it was a
learning process and people point out that using a
word like ‘‘cure’’ or the study itself puts treatments
in different order, obviously it does change the way
you talk to people about it.
T5-S4-F I had reservations [about T5]. I had to
think about it for a while before I agreed and
certainly in the original meetings about it I was a lit-
tle bit nervous about how I would cope with dealing
with young men with high grade disease etcetera, but
the more I thought about it the more sure I am that it
is the right thing to do. The whole business is full of
a lot of conflicts and, you know, apparent contradic-
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in T5 described the training and support they had received,
the reflection and changes it caused, and their eventual
increased levels of confidence and comfort with equipoise
and recruitment (Box 9).tions, but I’ve got to say that I’ve found myself ulti-
mately comfortable with it all.
T5-S10-F: There has been a remarkable evolution.
When I go back to the year 2000, 2001. Equipoise
was not even on the cards. People just could not
conceive that men would actually not receive treat-
ment. And over the years, this has changed dramati-
cally and the very people who were so much
against equipoise have been recruiting patients
because of equipoise.4. Discussion
This study has shown how doctors, particularly surgeons,
experienced and struggled with the concept of equipoise as
they carried out recruitment of patients to publicly funded
RCTs. None of them espoused a position of theoretical equi-
poise [9,10]; they were more pragmatic, relying on concep-
tions of uncertainty at an individual level or, more
commonly, on a lack of consensus about specific treatments
among colleaguesdcommunity equipoise [11,14]. The quest
to obtain better evidence to reduce uncertainty was a potent
reason for being involved in RCTs and was used frequently
as a justification for asking patients to consent to randomiza-
tion. Many doctors acknowledged that they had ‘‘hunches’’
or ‘‘gut instincts’’ that particular treatments were superior
in general or for specific patients or groups, and many expe-
rienced discomfort because of their clinical instincts and the
‘‘blurring’’ of equipoise around rigid RCT eligibility criteria.
Their discomfort affected their ability and willingness to re-
cruit. Some doctors tried to participate in RCTs even when
they had strong convictions about the superiority of their
preferred treatment option. They tried to rely on a sense of
community equipoise but could not avoid expressing their
views or discomfort. Those most committed to RCTs used
the need for evidence to suspend their hunches and provide
a justification for recruitment, but it seems likely that somewould have acted on their hunches, to the detriment of
recruitment [28]. Doctors in specialties in which RCTs were
common or there was a culture of peer support, such as
oncology, tended to find recruitment easier, but there were
particular issues in surgery in which clear convictions about
their approach, excitement about technical details, and an
imperative to practice skills led to RCT recruitment being
particularly problematic.
A lack of equipoise among surgeons has been previously
identified as a major reason for the small number of suc-
cessful RCTs in the specialty [30,31], leading to sugges-
tions that other study designs should be used [32]. This
study has shown that doctors in a range of specialties can
have strong personal preferences, although surgeons did
appear to experience particularly intense difficulties in this
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where surgery was compared with radiotherapy and no
active intervention for localized cancer, surgeons provided
with training and feedback learned how to express uncer-
tainty and engage more actively with patients during
recruitment [29]. As they became more comfortable with
these concepts, recruitment rose from 30% to 65% of
eligible patients [33].
The strengths of this study relate to the synthesis of inter-
view findings from doctors actively attempting recruitment
across six diverse and challenging RCTs. T2, T3, T4, and
T5 eventually completed recruitment with resource exten-
sions and adjusted sample sizes; T1 and T6 closed without
completing recruitment. The in-depth nature of the inter-
views enabled detailed discussion of views and issues,
permitting insights that would not have emerged with the
use of a questionnaire or structured schedule. Interviews
were conducted with surgeons and other clinical specialists
who can be particularly difficult to reach. The detailed inter-
view data revealed clear empirical evidence about the con-
flicts and discomforts experienced by doctors in relation
to evidence and equipoise during recruitment and allowed
the capture of issues in a range of clinical and RCT contexts,
as well as showing the capacity of training and support to
bring about changes over time. The limitations include that
interviews were carried out with a pragmatic sample of doc-
tors willing to discuss these issues in RCTs already experi-
encing recruitment difficulties, and so their views may not
be representative of others less involved in RCTs or in suc-
cessfully recruiting RCTs in which there may be more com-
fort with equipoise. As recruitment is often poor in RCTs,
however, it may be that other doctors could have even more
adverse views than found here. Interviews were carried out
over an extended period because it was important to capture
recruiters’ views when they were actively recruiting, but we
were reliant on RCT CIs being willing to collaborate with
the qualitative research and doctors agreeing to be inter-
viewed. This could limit the contemporary applicability of
the findings, although recruitment remains a serious diffi-
culty in many current RCTs. Different numbers of doctors
were recruited from each RCT because of their scale and in-
dividual willingness, and these factors, and that two-thirds
of those interviewed were surgeons, may have influenced
the findings. Relying only on interview data, rather than
including observations or recordings of recruitment appoint-
ments, also means that these findings should be considered
preliminary. Audio recording appointments proved difficult
in five of these six RCTs [19], but the program is gathering
these data in ongoing collaborations.
Poor recruitment is repeatedly identified as a serious
threat to RCTs [1,4], and this study has elucidated why it
is such a fragile process. RCTs should only be mounted
following a systematic review of existing evidence and
stringent regulation through research ethics and governance
procedures [34], but then, the key issues are whether clini-
cians will commit to recruitment and patients will agreeto participate. The concept of clinical equipoise was devel-
oped as an ethical justification for carrying out experimental
studies on humans [11]. There are strong advocates for its
continued use [15] or demise [17,18]. The somewhat
esoteric content of the theoretical debate is in sharp contrast
with the practical issues raised by the discomfort and
emotion expressed by doctors in this study. The quest for ev-
idence was a powerful imperative for these doctors, but they
struggled intellectually and emotionally with aspects of
equipoise. One solution might be that recruitment could
instead be undertaken by nurses, who have been shown to
be as effective as doctors [35], or research staff, who might
be able to present the RCT more neutrally without clinical
responsibility. These suggestions require further research,
although there is evidence that nurses’ perceptions of their
roles can also conflict with recruitment to RCTs, perhaps
even more so than doctors [28,36]. Another solution might
be to mandate training and support for whoever undertakes
recruitment, with audio recording of recruitment appoint-
ments to allow scrutiny of the quality of the information
they provide to patients, and feedback and support, as in
T5 [29]. Rather than agonizing over aspects of the theoret-
ical concept of equipoise, the focus of debate should shift to
the practical need to train and support recruiters to engage
actively with patients as partners in recruitment [37].
Several findings from this study could be further investi-
gated. Some doctors tried to recruit even when they held
very clear opinions about the most effective treatment.
Further research should explore whether their preferences
can be absorbed within community equipoise [13,38] and
whether they can or should recruit patients. The impact of
the strong emotion expressed by the doctors in this study,
also seen in another qualitative study [39], would also benefit
from further development of interventions to assuage it.
As one doctor eloquently put it, ‘‘inevitably you can
only get patients recruited within the equipoise of the
recruiter’’ (T2-S2). Ultimately, RCT recruitment relies on
a recruiter presenting the RCT clearly to potential partici-
pants. Doctors in this study, including surgeons, wanted
to participate in RCTs to gather high-quality evidence.
They tried to rely on a sense of community or individual
equipoise but experienced considerable discomfort, intel-
lectually and emotionally, in relation to their clinical and
research roles. Methods of training and support need to
be developed, as in T5, to enable doctors to gain greater un-
derstanding of key RCT concepts so that they can present
RCT information with comfort and engage more easily
with patients, enabling even the most challenging health-
care questions to be addressed through RCTs.Acknowledgments
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